Lipid-Lowering Agents Do Not Affect COVID-19-Related Mortality Outcomes
Lipid-lowering agents offer no clear benefit as an adjunctive therapy for reducing mortality in patients with COVID-19, according to research
Lipid-lowering agents offer no clear benefit as an adjunctive therapy for reducing mortality in patients with COVID-19, according to research
Surgery for indeterminate thyroid nodules decreased, which resulted in an increase in the occurrence of aggressive thyroid tumors, during the
Patients with nonalcoholic fatty liver disease (NAFLD) and liver biopsies who have type 2 diabetes (T2D) experience a quicker progression of fibrosis
Compared with hypnotic benzodiazepines, the use of melatonin is not associated with an increased risk for hip fracture incidence, according to
High-dose vitamin D supplementation has no significant clinical effect in preventing falls and fractures, according to study findings in Osteoporosis
While there are other important financial and nonfinancial goals, the greatest financial task of your life is to build a nest egg that will allow you
Bariatric-metabolic surgery is more effective than lifestyle modifications in treating nonalcoholic steatohepatitis (NASH) with obesity, according to
Cumulative glycated hemoglobin (HbA1c) levels over 9% are associated with a greater risk for dementia in patients with type 2 diabetes, according to
HealthDay News — Older Americans are increasingly likely to log into patient portals to access their health care information — but confidence
Equitable access to continuous glucose monitoring (CGM) can help alleviate the hemoglobin A1c disparities found between patients with type 1 diabetes
Weight fluctuations can lead to dangerous health outcomes, which include an elevated risk of heart failure and cardiovascular death, according to a
Risk for major adverse cardiovascular events (MACEs) in patients receiving antihyperglycemic therapy is affected by glycated hemoglobin (HbA1C)
Combination therapy with as many as 3 antihypertensive agents in 1 pill improves persistence to medication and reduces cardiovascular events and
Methimazole is an effective substitution for propylthiouracil as first-line treatment for patients with thyroid storm, according to study results
The Centers for Medicare and Medicaid (CMS) launched an investigation of 2 Medicare-covered hospitals — one in Missouri and one in Kansas — that